D. E. Shaw & Co., Inc. Evelo Biosciences, Inc. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.46 - $3.55 $5,445 - $13,241	-3,730 Reduced 16.26%	19,205 $41,000
Q1 2022 May 16, 2022	BUY	$2.66 - $6.63 $61,007 - $152,059	22,935 New	22,935 $78,000
Q3 2021 Nov 15, 2021	SELL	$6.79 - $13.9 $229,325 - $469,458	-33,774 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.43 - $16.6 $318,488 - $560,648	33,774 New	33,774 $464,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.